LDX 2.13% 4.8¢ lumos diagnostics holdings limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-41

  1. 992 Posts.
    lightbulb Created with Sketch. 136
    Nitpicking points from the overall report is silly which is what vacuum did. Revenue for product was in guidance with CEO commentary.

    Yearly revenue increased substantially on last year as example. Also, not a full flu season run with Febridx in the US and revenue in line with previous years revenue for other regions also.

    Revenue fluctuations will occur. Won’t always be consistently up each quarter fmd.
 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.